Biopharma News

Jan 12, 2015
BioPharm International
By BioPharm International Editors
Shire adds rare-disease portfolio with acquisition of NPS Pharma.
Jan 09, 2015
BioPharm International
The decision to skip an FDA panel advisory may allow the medication to be approved more quickly.
Jan 08, 2015
BioPharm International
Biogen Idec’s investigational monoclonal antibody met its primary endpoints in a recent Phase II for the treatment of acute optic neuritis.
Jan 06, 2015
BioPharm International
The exclusivity deal mirrors that of the recent deal between Express Scripts and AbbVie for Viekira Pak.
Jan 02, 2015
BioPharm International
In 2014, FDA approved 41 new novel medications, which is the highest number since 1996.
Dec 30, 2014
BioPharm International
Although competing therapies will continue to be released in the immuno-oncology space, efficacy profiles, combination regimens, and administration setting may influence a drug’s preferred status more than price.
Dec 23, 2014
BioPharm International
The partnership will focus on the discovery of antibodies against proteins that are not easily purified in functional form.
Dec 23, 2014
By BioPharm International Editors
Protein Sciences will evaluate sourcing Flublok from its Japanese licensee, UMN Pharma, which already runs a large-scale facility for the vaccine.
Dec 19, 2014
BioPharm International
Roche will use Dutalys’ DutaMab technology for the engineering of bispecific therapeutic antibodies.Roche Acquires Bispecific Antibody Developer Dutalys
Dec 19, 2014
BioPharm International
Roche will use Dutalys’ DutaMab technology for the engineering of bispecific therapeutic antibodies.
native1_300x100
lorem ipsum